Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

OncoMed Pharmaceuticals

Biotech & Life Sciences · Redwood City, United States · Founded 2004 · IPO 2013 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue
$27M
Latest reported FY

Investors

10 investors on OncoMed Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
The Vertical Group
Morgenthaler Ventures
Latterell Venture Partners
U.S. Venture Partners
Series B+ 6 investors entered at this stage
Phase4 Partners
DeNovo Ventures
Bay Partners
Adams Street Partners
Nomura Phase4 Ventures
Delphi Ventures

Global footprint

Where OncoMed Pharmaceuticals has talent and traffic

Web traffic by country
1.5K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

See OncoMed Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo